Inhibrx Biosciences Inc (NASDAQ:INBX) is a biotech company developing therapeutic candidates for various medical needs. Recent insider transactions show more buying than selling, indicating confidence in the company's prospects. Investors can find detailed valuation metrics and insights on INBX.